What is the appropriate management, including antibiotic choice, tetanus prophylaxis, and follow‑up, for an otherwise healthy 5‑year‑old boy with a suspected spider bite that has progressed to cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Suspected Spider Bite with Cellulitis in a 5-Year-Old

For an otherwise healthy 5-year-old with suspected spider bite and cellulitis, initiate oral cephalexin 25 mg/kg/day divided into four doses (or 500 mg four times daily if weight >40 kg) for 5 days, ensure tetanus immunization is current (administer 0.5 mL DTaP intramuscularly if last dose was >5 years ago or status unknown), elevate the affected extremity, and reassess within 24-48 hours for clinical improvement. 1, 2

First-Line Antibiotic Selection

Beta-lactam monotherapy is the standard of care for typical pediatric cellulitis, with a 96% success rate. 2 The preferred oral agents include:

  • Cephalexin 25 mg/kg/day divided every 6 hours (maximum 500 mg per dose) provides excellent coverage against beta-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus, the primary pathogens in typical cellulitis 1, 2, 3
  • Alternative options include dicloxacillin or amoxicillin-clavulanate if cephalexin is unavailable 1, 2

MRSA coverage is NOT routinely necessary for typical pediatric cellulitis. 2 However, spider bites that progress to severe soft tissue infections may harbor MRSA, particularly if there is purulent drainage, rapid progression, or failure of initial beta-lactam therapy. 4

When to Add MRSA Coverage

Add MRSA-active antibiotics only if the following specific risk factors are present:

  • Purulent drainage or exudate visible at the bite site 1, 2, 4
  • Severe pain out of proportion to examination findings (suggests necrotizing infection) 1, 4
  • Failure to improve after 48-72 hours of beta-lactam therapy 2, 4
  • Systemic toxicity (fever >38°C, tachycardia, altered mental status) 1, 2

If MRSA coverage is needed, use:

  • Clindamycin 10-13 mg/kg/dose orally every 6-8 hours (provides single-agent coverage for both streptococci and MRSA, but only if local clindamycin resistance <10%) 2, 5
  • Trimethoprim-sulfamethoxazole 4-6 mg/kg/dose twice daily PLUS cephalexin (combination therapy required because TMP-SMX lacks streptococcal coverage) 2

Critical Evidence from Spider Bite Infections

A retrospective study of 38 patients with serious soft tissue infections from spider bites found that 86.8% grew methicillin-resistant Staphylococcus aureus, and 29% had failed initial penicillin-based oral antibiotics. 4 This underscores the importance of:

  • Close monitoring within 24-48 hours to detect treatment failure early 1, 2, 4
  • Aggressive surgical debridement if the infection progresses despite antibiotics 4
  • Switching to MRSA-active therapy immediately if erythema expands, pain worsens, or purulent drainage develops 4

Treatment Duration

Treat for exactly 5 days if clinical improvement occurs (reduction in warmth, tenderness, and erythema). 1, 2 Extend treatment beyond 5 days only if symptoms have not improved within this timeframe. 1, 2 Traditional 7-14 day courses are no longer necessary for uncomplicated cellulitis. 2

Tetanus Prophylaxis

Verify tetanus immunization status immediately. 1

  • If the child has completed the primary DTaP series and the last dose was <5 years ago: no additional tetanus prophylaxis needed 1
  • If the last dose was >5 years ago OR status is unknown: administer DTaP 0.5 mL intramuscularly (for children <7 years) or Tdap (for children ≥7 years) 1
  • Spider bites are considered contaminated wounds requiring tetanus prophylaxis if immunization is not current 1

Essential Adjunctive Measures

  • Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage of edema and inflammatory substances 1, 2
  • Cleanse the wound with sterile normal saline (no need for iodine- or antibiotic-containing solutions) and remove superficial debris 1
  • Do NOT close or suture the wound if there is any sign of infection 1
  • Mark the borders of erythema with a pen to objectively track progression or improvement 1, 6

Hospitalization Criteria

Admit the child if any of the following are present:

  • Age <6 months with moderate-to-severe disease 2
  • Systemic inflammatory response syndrome (SIRS): fever >38°C, heart rate >90 bpm (age-adjusted), respiratory rate >24 breaths/min (age-adjusted) 1, 2
  • Hypotension, altered mental status, or confusion 1, 2
  • Severe pain out of proportion to examination, skin anesthesia, rapid progression, or "wooden-hard" subcutaneous tissues (suggests necrotizing fasciitis requiring emergent surgical consultation) 1, 4
  • Failure of outpatient therapy after 24-48 hours 1, 2

For hospitalized children requiring IV therapy:

  • Vancomycin 15 mg/kg IV every 6 hours is first-line for complicated cellulitis with MRSA risk factors 2
  • Clindamycin 10-13 mg/kg/dose IV every 6-8 hours is an alternative if the child is stable without bacteremia and local resistance is <10% 2

Follow-Up Protocol

Reassess within 24-48 hours (either by phone or office visit) to verify clinical response. 1, 2, 3 If the infection progresses despite appropriate antibiotics:

  • Switch to MRSA-active therapy immediately (clindamycin or TMP-SMX plus beta-lactam) 2, 4
  • Consider hospitalization for IV antibiotics if oral therapy fails 2, 4
  • Obtain surgical consultation urgently if necrotizing infection is suspected 1, 4

Common Pitfalls to Avoid

  • Do NOT routinely add MRSA coverage for typical cellulitis without specific risk factors—this represents overtreatment and increases antibiotic resistance 1, 2
  • Do NOT use doxycycline in children <8 years due to risk of permanent tooth discoloration and impaired bone growth 2
  • Do NOT use TMP-SMX as monotherapy for typical cellulitis—it lacks reliable streptococcal coverage and must be combined with a beta-lactam 2
  • Do NOT delay surgical consultation if any warning signs of necrotizing infection are present (severe pain, rapid progression, skin anesthesia, bullae) 1, 4
  • Do NOT extend antibiotics to 7-10 days automatically—only extend if clinical improvement has not occurred by day 5 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Cellulitis: A Review of Pathogenesis, Diagnosis, and Management.

The Medical clinics of North America, 2021

Related Questions

What is the best management approach for a patient with worsening cellulitis secondary to an unknown insect bite after failed operative management?
What is the dose of Bactrim (trimethoprim/sulfamethoxazole) for a 15kg child with cellulitis?
What is the appropriate evaluation and treatment for a 25‑year‑old healthy male who developed cellulitis with fever three days after a 1 cm abrasive wound on the dorsum of his right foot?
In a child with fever, irritability, and an enlarging, warm, tender, erythematous swelling of the lower left leg without fluctuance or systemic toxicity, what is the most appropriate initial treatment?
What are the antibiotic options for a 28-year-old female with vulvar cellulitis (inflammation of the skin and subcutaneous tissue)?
What is the appropriate management for a five‑year‑old child weighing about 18–20 kg with an unknown spider bite?
What are the recommended acyclovir dosing regimens for typical adult and pediatric patients with normal renal function, and how should the dose be adjusted for renal impairment?
What is the appropriate evaluation and treatment for a child who ingested rock salt and may have hypernatremia and volume depletion?
In an asymptomatic adult aged 40‑75 with intermediate 10‑year ASCVD risk (≈7‑20 %), when is a coronary calcium CT indicated and how should the calcium score (0, 1‑99, 100‑399, ≥400) guide statin and other therapy?
Does hydroxyzine cause skin rashes?
What supportive care measures are recommended for a healthy 5‑year‑old child with acute sinusitis and acute conjunctivitis, given no chronic illnesses or allergies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.